Home / Research and experimental development on chemicals (except medical and veterinary science)

HUALONG CHEMICAL TECHNOLOGY CONSULTING PTE. LTD.

Live CompanyUEN 202242464ZLocal Company

HUALONG CHEMICAL TECHNOLOGY CONSULTING PTE. LTD. is a local company in Singapore with UEN 202242464Z. It was registered on 29 Nov 2022, 3 years ago. Its status is Live Company. Its main activity is research and experimental development on chemicals (except medical and veterinary science).

UEN202242464Z
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered29 Nov 2022
Main activity (SSIC)72103 Research and experimental development on chemicals (except medical and veterinary science)
Secondary activity70209 Management consultancy services n.e.c.
Address45 TRAS STREET, #02-00, Singapore 078984
65 companies at this address
AreaOutram · District 2 (Anson, Tanjong Pagar)
Nearest stationTanjong Pagar MRT, about 201 m
Officers5
Last annual return29 Dec 2025

Newer companies in research and experimental development on chemicals (except medical and veterinary science)

  • ANVL PTE. LTD.202639992Z · 31 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • BAMCORE TECH PTE. LTD.202639601K · 28 Aug 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • PMA NANO CARBON TECHNOLOGY PTE. LTD.202616965H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • SILVERX TECHNOLOGY PTE. LTD.202616838H · 16 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • INNATUS THERAPEUTICS PTE. LTD.202616249E · 13 Apr 2026 · Research and experimental development on chemicals (except medical and veterinary science)
  • ABUNDANCE SPECIALTY CHEMICALS PTE. LTD.202611248M · 13 Mar 2026 · Research and experimental development on chemicals (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.